28 Jan 2014 | 04:36 pm |
International law firm Pinsent Masons has advised IP Group on its proposed acquisition by way of a scheme of arrangement of investment business Fusion IP at a price of more than £85 million.
Corporate partner Russell Booker led a team advising the IP commercialisation business on the deal which was announced at the same as a £75 million fund raising and open offer of 45.5 million shares to raise up to £75m by way of a firm placing, open offer and placing.
Commenting on the deal, Russell Booker, said: "The fund raising and acquisition is transformational for both companies providing broader capabilities across the UK. Fusion and IP Group are both innovative in the field of intellectual property and provide essential research across a number of areas.
The deal clearly highlights Pinsent Masons' expertise across the IP and life sciences industry as well as its corporate capabilities."
IP Group, which acquired 20.1 per cent of Fusion in 2009, works with 11 universities in the UK supporting IP development in fields as diverse as computer-aided drug discovery to fuel cell technology and graphene. Fusion currently works with four universities.
The capital raising will enable IP Group to accelerate growth across a number of sectors pursue, novel therapeutics and consider future spin-out companies.
Multinational law firm Pinsent Masons has advised Simpson Malt Limited on a £90m asset based lending (ABL) facility with PNC Business Credit.
Pinsent Masons was named 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards, which was held virtually on 27 November 2020.
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on